Will you be attending the Global CMT Research Convention this Friday and Saturday, 16-17 September in Cambridge, MA?
The event is the largest global convention focussed on Charcot-Marie-Tooth, bringing together the research community and patients in a single event.
Join our CEO, Thomas Holm Pedersen on Saturday 17 Sep where he’ll be speaking as a panellist on the ‘Surge of Momentum from Biotechs’ panel at 2:30-3:45pm EDT discussing NMD Pharma’s work on CMT.
Thomas Holm Pedersen speaks at The Global CMT Research Convention
Previous
Previous
FDA grants Orphan Drug Designation for NMD670 for the Treatment of Myasthenia Gravis
Next
Next